Applied Clinical Trials Direct
Having trouble viewing this e-mail? Click here.
  May 14, 2014
In This Edition
News Roundup: Rare Cancers High on Orphan Drug Activity
Articles: Shifting Paradigm in Clinical Trial Design for Anti-Cancer Drugs
Blog Posts: FDA, Viewing from a Different Lens
Marketplace: Marketplace

News Roundup
bullet Rare Cancers High on Orphan Drug Activity
bullet Project Data Sphere Shares De-Identified Oncology Data
bullet Ovarian Cancer Care Diagnostics Addressed in Collaboration

Articles
bullet Immunotherapy Clinical Trials in Melanoma: Overcoming Recruitment Challenges
bullet Shifting Paradigm in Clinical Trial Design for Anti-Cancer Drugs

Blogs Posts
bullet FDA, Viewing from a Different Lens
bullet Observations from AACR 2014

Events
bullet Clinical Quality By Design.... Last Day Today!
Marketplace

Sponsored
Oracle Corporation
This white paper examines the current state of risk-based monitoring and builds on extensive work done by TransCelerate BioPharma as well as regulatory authorities worldwide. Read more


Sponsored
ACRP
Formal GCP Training for CRCs, CRAs and Investigators
From comprehensive introductory training for all clinical research professionals to role-specific courses for experienced Monitors/CRAs, Coordinators and Investigators, ACRP offers the formal GCP training solutions you need for yourself or your staff.Read more


 
CHINA REPORT
China is the third largest pharmaceutical market in the world and will become the second largest ahead of Japan by 2015. Everything you need to know to do business in the country; key economic sector data and exclusive interviews from regional leaders. Read More.
Follow Us

Ask The Editor

Lisa Henderson
Editor in Chief lhenderson@advanstar.com